Literature DB >> 19109865

Scutellaria barbate extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3.

Zhi-Jun Dai1, Xi-Jing Wang, Zong-Fang Li, Zong-Zheng Ji, Hong-Tao Ren, Wei Tang, Xiao-Xu Liu, Hua-Feng Kang, Hai-Tao Guan, Ling-Qin Song.   

Abstract

AIM: To study the growth inhibitory and apoptotic effects of Scutellaria barbata D.Don (S. barbata) and to determine the underlying mechanism of its antitumor activity in mouse liver cancer cell line H22.
METHODS: Proliferation of H22 cells was examined by MTT assay. Cellular morphology of PC-2 cells was observed under fluorescence microscope and transmission electron microscope (EM). Mitochondrial transmembrane potential was determined under laser scanning confocal microscope (LSCM) with rhodamine 123 staining. Flow cytometry was performed to analyze the cell cycle of H22 cells with propidium iodide staining. Protein level of cytochrome C and caspase-3 was measured by semi-quantitive RT-PCR and Western blot analysis. Activity of caspase-3 enzyme was measured by spectrofluorometry.
RESULTS: MTT assay showed that extracts from S. barbata (ESB) could inhibit the proliferation of H22 cells in a time-dependent manner. Among the various phases of cell cycle, the percentage of cells in S phase was significantly decreased, while the percentage of cells in G(1) phase was increased. Flow cytometry assay also showed that ESB had a positive effect on apoptosis. Typical apoptotic morphologies such as condensation and fragmentation of nuclei and blebbing membrane of apoptotic cells could be observed under transmission electron microscope and fluorescence microscope. To further investige the molecular mechanism behind ESB-induced apoptosis, ESB-treated cells rapidly lost their mitochondrial transmembrane potential, released mitochondrial cytochrome C into cytosol, and induced caspase-3 activity in a dose-dependent manner.
CONCLUSION: ESB can effectively inhibit the proliferation and induce apoptosis of H22 cells involving loss of mitochondrial transmembrane potential, release of cytochrome C, and activation of caspase-3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109865      PMCID: PMC2778115          DOI: 10.3748/wjg.14.7321

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

Review 1.  Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review).

Authors:  Sudhir Gupta
Journal:  Int J Oncol       Date:  2003-01       Impact factor: 5.650

2.  Scutellaria barbata D. Don induces c-fos gene expression in human uterine leiomyomal cells by activating beta2-adrenergic receptors.

Authors:  T-K Lee; H-L Cho; D-I Kim; Y-C Lee; C-H Kim
Journal:  Int J Gynecol Cancer       Date:  2004 May-Jun       Impact factor: 3.437

3.  Chemical composition and antimicrobial activity of the essential oil of Scutellaria barbata.

Authors:  Jianqing Yu; Jiachuan Lei; Huaidong Yu; Xuan Cai; Guolin Zou
Journal:  Phytochemistry       Date:  2004-04       Impact factor: 4.072

4.  Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta.

Authors:  Seiichiro Nishida; Hiroyasu Satoh
Journal:  Life Sci       Date:  2003-04-25       Impact factor: 5.037

5.  Screening assays for the mitochondrial permeability transition using a fluorescence multiwell plate reader.

Authors:  J R Blattner; L He; J J Lemasters
Journal:  Anal Biochem       Date:  2001-08-15       Impact factor: 3.365

6.  [Anti-proliferative and apoptosis-inducing activity of Scutellaria barbate containing serum on mouse's hepatoma H22 cells].

Authors:  Zhi-Jun Dai; Xiao-Xu Liu; Qian Xue; Zong-Zheng Ji; Xi-Jing Wang; Hua-Feng Kang; Hai-Tao Guan; Xiao-Bin Ma; Hong-Tao Ren
Journal:  Zhong Yao Cai       Date:  2008-04

7.  Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549.

Authors:  Xiaolu Yin; Jiangbing Zhou; Chunfa Jie; Dongming Xing; Ying Zhang
Journal:  Life Sci       Date:  2004-09-17       Impact factor: 5.037

8.  Inhibitory effects of Scutellaria barbata D. Don on human uterine leiomyomal smooth muscle cell proliferation through cell cycle analysis.

Authors:  Tae-Kyun Lee; Dong-Kyu Lee; Dong-Il Kim; Young-Choon Lee; Young-Chae Chang; Cheorl-Ho Kim
Journal:  Int Immunopharmacol       Date:  2004-03       Impact factor: 4.932

9.  Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway.

Authors:  Yun-Yi Cha; Eun-Ok Lee; Hyo-Jeong Lee; Young-Doo Park; Seong-Gyu Ko; Dong-Hee Kim; Hyung-Min Kim; In-Cheol Kang; Sung-Hoon Kim
Journal:  Clin Chim Acta       Date:  2004-10       Impact factor: 3.786

10.  The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin.

Authors:  C C Lin; D E Shieh
Journal:  Am J Chin Med       Date:  1996       Impact factor: 4.667

View more
  22 in total

1.  Study on norcantharidin-induced apoptosis in SMMC-7721 cells through mitochondrial pathways.

Authors:  Xian-qian Li; Shi-he Shao; Gui-lian Fu; Xiao-hong Han; Hong Gao
Journal:  Chin J Integr Med       Date:  2010-09-25       Impact factor: 1.978

2.  Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract.

Authors:  Zong-Fang Li; Zhi-Dong Wang; Yuan-Yuan Ji; Shu Zhang; Chen Huang; Jun Li; Xian-Ming Xia
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

3.  BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype.

Authors:  Crystal N Marconett; Travis J Morgenstern; Adrianna K San Roman; Shyam N Sundar; Ankur K Singhal; Gary L Firestone
Journal:  Cancer Biol Ther       Date:  2010-08-20       Impact factor: 4.742

4.  A traditional Chinese medicine compound (Jian Er) for presbycusis in a mouse model: Reduction of apoptosis and protection of cochlear sensorineural cells and hearing.

Authors:  Yi Xuan; Dalian Ding; Weijun Xuan; Liyi Huang; Junbo Tang; Yulong Wei; Sizhong Chen; Michael R Hamblin
Journal:  Int J Herb Med       Date:  2018 Nov-Dec

5.  Tumor cell-released autophagosomes (TRAP) enhance apoptosis and immunosuppressive functions of neutrophils.

Authors:  Rong Gao; Jie Ma; Zhifa Wen; Peiying Yang; Jinjin Zhao; Meng Xue; Yongqiang Chen; Mohanad Aldarouish; Hong-Ming Hu; Xue-Jun Zhu; Ning Pan; Li-Xin Wang
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110

6.  A drug-biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia.

Authors:  Teng Wang; Chun-Yi Lyu; Yue-Hua Jiang; Xue-Yan Dong; Yan Wang; Zong-Hong Li; Jin-Xin Wang; Rui-Rong Xu
Journal:  Mol Divers       Date:  2020-07-16       Impact factor: 2.943

7.  [Interference of CTPS gene promotes toosendanin-induced apoptosis of human gastric cancer MKN-45 cells].

Authors:  H Luo; Y Pan; W Chen; W Zhang; S Shao; Q Yang; T Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-08-20

8.  A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells.

Authors:  Ashok Kumar; Baljinder Singh; Girish Mahajan; Parduman R Sharma; Sandip B Bharate; Mubashir J Mintoo; Dilip M Mondhe
Journal:  Tumour Biol       Date:  2016-07-24

9.  Induction of apoptosis by total flavonoids from Scutellaria barbata D. Don in human hepatocarcinoma MHCC97-H cells via the mitochondrial pathway.

Authors:  Jie Gao; Wang-Feng Lu; Zhi-Jun Dai; Shuai Lin; Yang Zhao; Sha Li; Nuan-Nuan Zhao; Xi-Jing Wang; Hua-Feng Kang; Xiao-Bin Ma; Wang-Gang Zhang
Journal:  Tumour Biol       Date:  2013-11-13

10.  Traditional herbal medicine: a review of potential of inhibitory hepatocellular carcinoma in basic research and clinical trial.

Authors:  Zhidong Wang; Jun Li; Yuanyuan Ji; Peng An; Shu Zhang; Zongfang Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.